In response to growing demand worldwide, WuXi AppTec has commissioned two new peptide plants, one each at its Changzhou and Taixing sites in China. Both use digital operation systems with automated solvent delivery, in order to optimise production consistency, minimise human errors and reduce production cycle time.

This investment will increase the company’s total solid-phase peptide synthesis (SPPS) reactor volume to 32,000 litres. It also marks the official launch of Taixing as WuXi AppTec’s fifth API production sites.

Apical Oleochemical (Taixing), an RGE China operation, has celebrated on the completion of the initial phase of its ‘oleochemical industry integration project’ at Taixing in Jiangsu province. Construction for the initial phase began in July 2021 and was completed in March 2023, with production starting in June.

Seqens is to make an investment of nearly RMB 300 million (€40 million) in three major new production capacity projects for the healthcare and cosmetics markets at Taixing and Wuxi, China. CEO Pierre Luzeau (pictured) announced this during a meeting President Macron had with between President Xi Jinping and Macron in Beijing on 6 April.